CapeOX + bevacizumab

DRUG2 trials

Sponsors

Tang-Du Hospital, The First Affiliated Hospital with Nanjing Medical University

Conditions

Microsatellite Stable (MSS) Colorectal Cancer (CRC)RAS-mutant Colorectal CancerRectal CancerUnresectable Metastatic Colorectal Cancer

Phase 2

SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.

Not yet recruitingNCT06835179

The First Affiliated Hospital with Nanjing Medical UniversityMicrosatellite Stable (MSS) Colorectal Cancer (CRC), RAS-mutant Colorectal Cancer, Unresectable Metastatic Colorectal Cancer

Start: 2025-02-28End: 2027-05-31Target: 28Updated: 2025-02-19

Unknown Phase

Treatment of Low Locally Advanced Rectal Cancer With Radiotherapy Removal TNT Plus Neoadjuvant Therapy

Not yet recruitingNCT06035133

Tang-Du HospitalRectal Cancer

Start: 2023-11-10End: 2027-11-10Target: 213Updated: 2023-09-13